Company Analysis

AtriCure, Inc. (ATRC)

Nasdaq: ATRC · Surgical & Medical Instruments & Apparatus · Mason, OH · filing with the SEC since 2005
Grade6.6
◀ Past 6.0● Present 7.4▶ Future 6.3
The companyfiscal 2025, as filed
Revenue$535M+14.9%
Net income-$11.4M+74.4%
Earnings per share$-0.24+74.7%
Operating cash flow$57.3M+369.8%
Cash$167M+36.4%
Debt$61.9M0.0%
Shareholders’ equity$492M+6.7%
Shares, diluted47.8M+1.7%
Return on equity-2.3%
The recordfrom its filings
Filings in 202678
Newest filingNov 10 · 4
Annual reportFeb 19, 2026
Quarterly reportNov 4, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$5.1M
Insider buys, 12 months$0.00
Patents granted241
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $590MNet income $14.9MCash from operations $68.5Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 10, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Sep 24, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton ATRC · research, not advice